Bovine hemoglobin‐based oxygen‐carrying solution (HBOC‐201) improves flap survival in a rat model of epigastric flap failure

Despite continued improvements in surgical technique and postoperative management of pedicled flaps, partial flap necrosis continues to be a substantial problem. Several researchers sought interventions that would decrease the incidence of this complication. The hypothesis of this study is that a bovine hemoglobin‐based, oxygen‐carrying solution (HBOC‐201) will increase oxygen delivery, thus decreasing the area of necrosis of the marginally perfused portions of a pedicled flap. Eighty male Sprague‐Dawley rats were randomly assigned to one of four groups (20 animals in each group): group 1, controls (surgical creation of flap only); group 2, HBOC‐201, 2 g i.v., administered preoperatively and on days 3 and 5; group 3, HBOC‐201, 4 g i.v., administered preoperatively and on days 3 and 5; and group 4, hemodilution (lactated Ringer's solution) administered preoperatively and on days 3 and 5. A ventral fasciocutaneous flap (5 × 7 cm) was elevated, based on unilateral superficial inferior epigastric vessels, and the flap was replaced and sutured. Animals were examined daily and euthanized on day 7. Prior to euthanasia, digital photographs were taken of each subject, and the images were analyzed for total area of the flap and area of necrosis, using ImagePro® software. Using the calculated percentage of necrosis for each animal, a mean value of percent necrosis was obtained for each animal group and used for statistical analysis. Animals in group 2 demonstrated a decreased area of necrosis when compared with the control group (9.14% vs. 22.24%, P = 0.014). In conclusion, the oxygen therapeutic HBOC‐201, at a dose of 2 g, administered preoperatively and on days 3 and 5, decreased the area of necrosis in a rat model of epigastric skin‐flap failure. Further investigation of this drug and its effects on flap survival is warranted. © 2006 Wiley‐Liss, Inc. Microsurgery, 2006.

[1]  P. Buehler,et al.  Toxicities of hemoglobin solutions: in search of in‐vitro and in‐vivo model systems , 2004, Transfusion.

[2]  D. Jenkins,et al.  The polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) is not toxic to neural cells in culture. , 2002, The Journal of trauma.

[3]  T. Nakatsuka,et al.  Clinical Use of Amrinone (a Selective Phosphodiesterase III Inhibitor) in Reconstructive Surgery , 2001, Plastic and reconstructive surgery.

[4]  L. Jenkins,et al.  Hypotensive resuscitation using a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) leads to reversal of anaerobic metabolism. , 2001, The Journal of trauma.

[5]  K. Fischer,et al.  Improvement of Skin Paddle Survival by Application of Vascular Endothelial Growth Factor in a Rat TRAM Flap Model , 2001, Annals of plastic surgery.

[6]  Nancy H. Kelly,et al.  Absence of immunopathology associated with repeated IV administration of bovine Hb‐based oxygen carrier in dogs , 2001, Transfusion.

[7]  M. Siemionow,et al.  Improved perfusion after subcritical ischemia in muscle flaps treated with vascular endothelial growth factor. , 2000, Plastic and reconstructive surgery.

[8]  M. Siemionow,et al.  Tissue-plasminogen activator restores muscle flap perfusion in the rat. , 1999, The Journal of hand surgery.

[9]  H. Akbaş,et al.  Effect of Parenteral Pentoxifylline and Topical Nitroglycerin on Skin Flap Survival , 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[10]  E. Browne,et al.  Modification in Flap Design of the Epigastric Artery Flap in Rats–A New Experimental Flap Model , 1997, Annals of plastic surgery.

[11]  J. Schulte am Esch,et al.  Bovine hemoglobin increases skeletal muscle oxygenation during 95% artificial arterial stenosis. , 1997, Surgery.

[12]  E. Browne,et al.  Effect of Vascular Endothelial Growth Factor (VEGF) on Survival of Random Extension of Axial Pattern Skin Flaps in the Rat , 1996, Annals of plastic surgery.

[13]  G. S. Hughes,et al.  Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. , 1996, Critical care medicine.

[14]  M. Miller,et al.  Comparison of the rectus abdominis free flap with the pectoralis major myocutaneous flap for reconstructions in the head and neck. , 1992, American journal of surgery.

[15]  A. Roth,et al.  Augmentation of skin flap survival by parenteral pentoxifylline. , 1988, British journal of plastic surgery.

[16]  S. Ramasastry,et al.  Effect of Fluosol-DA (20%) on Skin Flap Survival in Rats , 1985, Annals of Plastic Surgery.

[17]  J. D. Hellums,et al.  Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary as a model of hemoglobin-based oxygen carrier performance. , 1998, Microvascular research.